Have our formalin-fixed, paraffin-embedded
(FFPE) PDX slides in hand for biomarker analysis within days.
FFPE PDX slides from JAX enable fast and easy screening of your tissue sample for your target of interest.
Available starting at $45 per slide
JAX offers AML patient-derived xenograft (PDX) models with varying mutational profiles and treatment histories.
Our preclinical testing facility uses the Patient-Derived-Xenograft (PDX) platform to predict the effectiveness of novel or existing therapeutics on over 400 genetically characterized clinically relevant cancer models.
Over 400 patient-derived xenograft (PDX) tumors are available for engrafting into immunocompromised NSG™ mice for shipment to your facility or use in JAX-directed preclinical efficacy studies.
Allow essential cookies
Required for basic site operations.
Allow analytics cookies
Used to analyze web traffic to improve the user experience.
Allow marketing cookies
Used to deliver personalized information and tailor communications.